Literature DB >> 17622765

Intrarenal cytokine and chemokine gene expression and kidney graft outcome.

Petra Hribova1, Jiri Lacha, Katja Kotsch, Hans-Dieter Volk, Irena Brabcova, Jelena Skibova, Stefan Vitko, Ondrej Viklicky.   

Abstract

AIMS: Proinflammatory cytokines are thought to play an important role in various kidney graft diseases resulting in interstitial fibrosis and tubular atrophy frequently found in case biopsies. To explore the role of various cytokines and chemokines in the long-term graft outcome, the transcription patterns of their genes in kidney allograft biopsies were evaluated.
METHODS: The real-time RT-PCR was used to identify intragraft mRNA expression of cytokines and chemokines in 74 kidney graft recipients and the results were correlated with histological and clinical parameters and long-term graft outcome.
RESULTS: We observed up-regulated IL-10 (p < 0.001), TGF-beta1, IL-6, MCP-1, RANTES (p < 0.01) and TNF-alpha (p < 0.05) mRNA expression in patients with chronic allograft nephropathy (CAN) as compared to controls. There were positive correlations between the mRNA expression of IL-6 (p < 0.001), IL-10 (p < 0.01), TNF-alpha, MCP-1 (p < 0.05) and the proteinuria. The up-regulation of intrarenal MCP-1 in patients with CAN increased the risk for the graft failure within the next 42 months (OR 5.1, p < 0.05). Kaplan-Meier survival analysis revealed that proteinuria and higher intragraft expression of TGF-beta1 and MCP-1 predict a poor kidney graft outcome.
CONCLUSION: Expression patterns of intrarenal proinflammatory genes might discriminate patients at a higher risk for the earlier allograft failure. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622765     DOI: 10.1159/000105134

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  7 in total

1.  Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection.

Authors:  Miguel Hueso; Estanis Navarro; Francesc Moreso; Francisco O'Valle; Mercè Pérez-Riba; Raimundo García Del Moral; Josep M Grinyó; Daniel Serón
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

2.  Clinical importance of chemokines and inflammatory cytokines for patient care following percutaneous nephrolithotripsy.

Authors:  Junrong Wang; Wei Wang; Wei Guo; Yanru Ma; Tianhui Ji; Baodi Zhang
Journal:  Exp Ther Med       Date:  2017-12-15       Impact factor: 2.447

3.  Molecular phenotypes of acute rejection predict kidney graft prognosis.

Authors:  Ondrej Viklicky; Petra Hribova; Hans-Dieter Volk; Janka Slatinska; Jan Petrasek; Stepan Bandur; Eva Honsova; Petra Reinke
Journal:  J Am Soc Nephrol       Date:  2009-09-24       Impact factor: 10.121

Review 4.  Molecular Assessment of Kidney Allografts: Are We Closer to a Daily Routine?

Authors:  A Trailin; P Hruba; O Viklicky
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

Review 5.  Significance of urinary proteome pattern in renal allograft recipients.

Authors:  Sufi M Suhail
Journal:  J Transplant       Date:  2014-03-13

6.  Gene expression profile in delay graft function: inflammatory markers are associated with recipient and donor risk factors.

Authors:  Diego Guerrieri; Luis Re; Jorgelina Petroni; Nella Ambrosi; Roxana E Pilotti; H Eduardo Chuluyan; Domingo Casadei; Claudio Incardona
Journal:  Mediators Inflamm       Date:  2014-05-19       Impact factor: 4.711

7.  CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation.

Authors:  Alena Sekerkova; Eva Krepsova; Eva Brabcova; Janka Slatinska; Ondrej Viklicky; Vera Lanska; Ilja Striz
Journal:  BMC Immunol       Date:  2014-02-06       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.